A nonsurgical permanent contraception stakeholder advisory committee: FHI 360’s experience

As part of its research on nonsurgical permanent contraception, FHI 360 created a committee of women’s health advocates to address the controversy surrounding quinacrine. The committee facilitated communication between stakeholders and researchers and represented user perspectives. This report summarizes the process for establishing the committee, delineates the successes and challenges, and specifies recommendations for other organizations considering stakeholder collaboration.